Apexigen logo
VerifiedBiotechnology Research

Apexigen

Apexigen is a clinical-stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics for the treatment of cancer with an emphasis on new immuno-oncology products designed to harness the patient’s immune system to combat and eradicate cancer. Its lead immuno-oncology drug candidate, sotigalimab, is a potent immune-activating antibody against CD40 currently in Phase 2 clinical development.

7-day free trial · no credit card

HeadquartersSan Carlos, United StatesEmployees8(11 to 50)Annual revenue$1M to <$10MWebsiteapexigen.comLinkedIn profileLinkedIn

Verified contacts

7

available on Kipplo

LinkedIn employees

8

11 to 50 range

Open roles

no listings

Distinct roles

4

indexed titles

Tech stack

1

tools in use

Monthly traffic

168

organic / mo

Sign up free to see all 7 verified contacts at Apexigen

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

7 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Apexigen

4 distinct titles indexed · top 4 shown.

  • 1accounting manager
  • 1consultant at apexigen
  • 1executive director head of clinical operations
  • 1research intern

Sign up to unlock all 7 contacts at Apexigen

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 7 verified contacts at Apexigen

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Apexigen | Kipplo Discover